Comparing second-line treatments for pneumocystis pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests different antibiotics for people with pneumocystis pneumonia who cannot take the standard treatment. It aims to find the best alternative therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a weakened immune system (from HIV, cancer, organ transplant, or other causes).
- You have been diagnosed with pneumocystis pneumonia (a lung infection).
- You cannot take the usual antibiotic (trimethoprim-sulfamethoxazole) because of allergy, side effects, or failure.
- You have not taken more than 7 days of any treatment for this infection already.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
This trial is testing whether a shorter or longer course of steroids works better for people recovering from severe Pneumocystis pneumonia (a lung infection). If you are 18 or older and have been on steroids for about 10 days but no longer need extra oxygen, you may be able to join.
This trial tests a new way to diagnose pneumocystis, a lung infection that can affect people with weakened immune systems. It may help find the infection faster and more accurately using samples taken from your lungs.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
This trial tests an inhaled version of the drug caspofungin as an add-on treatment for people with severe Pneumocystis pneumonia. It aims to see if breathing in the drug can help fight the infection better than the standard treatment alone.
This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.
Hear when a new Pneumocystis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.